Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia
Neurocrine Biosciences
· 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
tardive dyskinesia (td), interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Dermal Thermometry and Self-Care of High Risk Diabetic Patients
#1104340
Intelligent Simulated Patient System for Gastroenterology Education
#1104341
Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy
#1104342
Stereotactic Radiosurgery in Treating Patients With Brain Metastases
#1104343
Effect of Occupational Therapy at Home E-Rehabilitation (OTHER) for Persons Post-stroke
#1104344
Record
· ID 800777
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.